FDA 483 - Ionetix Corporation - May 01, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Ionetix Corporation in Miami, FL, a PET drug manufacturer, was cited for significant deficiencies in facility control, equipment maintenance, laboratory methods, and quality systems during an FDA inspection. The observations highlight issues with contamination prevention in cleanrooms, inadequate equipment setup, conflicting environmental monitoring procedures, insufficient corrective actions for sterility failures, and lack of proper resources for QC personnel, with several issues being repeat observations.
ID · 8a2ae2dc-81e1-4683-bd95-e077c86b21b1